Little Green Pharma (ASX:LGP) signed a binding sale and purchase agreement to acquire HHI (Australia), owner of the Health House medicinal cannabis distribution business, for AU$375,000, according to a Wednesday filing with the Australian bourse.
The company will absorb Health House's estimated AU$350,000 net liability position once the deal is completed.
Health House's ultimate parent company, Melodiol Global Health, had listed the business for sale at AU$10.9 million in September 2024.
The acquisition is expected to close Wednesday, the filing said.
The ASX-listed medicinal cannabis company's shares rose nearly 5% in recent Wednesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.